Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CACNA1B | Q00975 | 12/20 | 0.47 |
| ▸ | MEN1 | O00255 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | HTR2A | P28223 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7352294 | 0.89 | CACNA1B (0.46) | CACNA1BMEN1KMT2AKDM4EMAPT | |
| SCHEMBL7351957 | 0.88 | CACNA1B (0.51) | CACNA1BMEN1KMT2A | |
| SCHEMBL7352934 | 0.87 | CACNA1B (0.61) | CACNA1BMEN1KMT2A | |
| SCHEMBL7351747 | 0.86 | CACNA1B (0.44) | CACNA1BMEN1KMT2AKDM4EMAPT | |
| SCHEMBL7349295 | 0.86 | CACNA1B (0.56) | CACNA1BMEN1KMT2A | |
| SCHEMBL7357575 | 0.85 | CACNA1B (0.47) | CACNA1BMEN1KMT2A | |
| SCHEMBL7043358 | 0.81 | CACNA1B (0.57) | CACNA1B | |
| SCHEMBL7037552 | 0.81 | CACNA1B (0.57) | CACNA1B | |
| SCHEMBL7043102 | 0.81 | CACNA1B (0.57) | CACNA1B | |
| SCHEMBL7356401 | 0.81 | CACNA1B (0.62) | CACNA1BMEN1KMT2AMAPTL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1999007689-A1 | ANILINE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS | WARNER-LAMBERT COMPANY (US) | 1999-02-18 | — | — | WO | claimed |